Head and Neck Neoplasms: all 2,403 studies

Page 23 of 25. Open to participants first (559), then studies with results posted, then the rest; newest registration first within each.

• Doxil Topotecan Doublet Cancer StudyCompletedNCT00252889Phase 1
• S-Frame CT Immobilization Masks For Patients Undergoing Radiation Therapy For Head and Neck CancerCompletedNCT00252473Phase 2
• Resistance Exercise Training for the Shoulder and Neck Following Surgery for Head and Neck CancerCompletedNCT00248235Phase 2/3
• Study to Calculate the Radiation Dosimetry in Subjects With Head and Neck CancerCompletedNCT00245349
• Docetaxel and Radiation Therapy in Treating Patients With Stage II or Stage III Cancer of the Larynx or HypopharynxCompletedNCT00243113Phase 2
• ZD1839 (IRESSA™) in Combination With Docetaxel & Cisplatin in Subjects With Metastatic Head & Neck CancerCompletedNCT00242762Phase 2
• IRESSA in Combination With Cisplatin & Radiotherapy in Patients With Advanced Head & Neck CarcinomaCompletedNCT00242749Phase 2
• Gefitinib (Iressa) in Combo With Chemoradiation in Patients With Locally Advanced Head & Neck CancerCompletedNCT00239304Phase 1/2
• Indirect Magnetic Resonance Lymphangiography of the Head and Neck Region Using Conventional Gadolinium-based ContrastCompletedNCT00230295Not applicable
• The Role of FDG PET in Radiation Treatment Planning for Head and Neck CancersCompletedNCT00230269
• Treatment Outcomes and Quality of Life After IMRT Treatments of Head and Neck CancersCompletedNCT00230256
• Safety and Efficacy of RK0202 in Oral MucositisCompletedNCT00230191Phase 2
• Evaluation of Esomeprazole in Treating Gastro-esophageal Reflux Disease (GERD) in Head and Neck Cancer Patients Exposed to Radiation TherapyTerminatedNCT00222079Not applicable
• Docetaxel and Capecitabine for First Line Treatment of Metastatic Squamous Cell Carcinoma of the Head & NeckTerminatedNCT00216138Phase 2
• Effects of Swallowing Therapy in Head and Neck CancerWithdrawnNCT00214305Not applicable
• A Study of Chemoradiotherapy for Intermediate Stage/Selected Stage IV Cancers of the Head and NeckCompletedNCT00203905Phase 2
• Assessment of Early Genetic Changes in SmokersTerminatedNCT00200408
• Efficacy and Activity of BAY 43-9006 in Patients With Recurrent and/or Metastatic Head and Neck CancerCompletedNCT00199160Phase 2
• Medpulser Electroporation With Bleomycin Study to Treat Posterior Head and Neck Squamous Cell CarcinomaTerminatedNCT00198328Phase 3
• Medpulser Electroporation With Bleomycin Study to Treat Anterior Head and Neck Squamous Cell CarcinomaTerminatedNCT00198315Phase 3
• Study Using the Medpulser Electroporation System With Bleomycin to Treat Head and Neck CancerCompletedNCT00198263Phase 4
• Safety Trial of IRESSA, Cisplatin and Radiation Therapy for Patients With Head and Neck CancerTerminatedNCT00195078Phase 1/2
• Chemotherapy Plus Gefitinib Followed by Chemotherapy, Radiation Therapy, and Gefitinib For Head and Neck CancerCompletedNCT00193284Phase 2
• A Longitudinal Study of Plasma EBV DNA in Nasopharyngeal Carcinoma From Both Endemic and Non-Endemic Patient PopulationsCompletedNCT00186433
• Cisplatin and ZD1839 + Re-Irradiation in Recurrent Squamous Cell Cancer of the Head and NeckCompletedNCT00185835Phase 1
• The Role of CT-PET-MRI Image Fusion in Determining Radiation Treatment Volumes of Head-and-Neck Cancer PatientsCompletedNCT00184860Not applicable
• Reirradiation With Concomitant Chemotherapy After Salvage Surgery for Recurrence of Head and Neck Cancer in Irradiated AreaStatus unknownNCT00180934Phase 3
• Study of Imatinib (Glivec) in Patients With Adenoid Cystic Carcinoma of the Head and NeckStatus unknownNCT00180921Phase 2
• Tumor Metabolism of Head and Neck Cancer in Patients Who Underwent Radiation Therapy Measured With F-18-FDG-PETCompletedNCT00180245
• Tumor Hypoxia of Head-and-neck Cancer Underwent Radiation Therapy Measured With F-18-FMISOCompletedNCT00180180
• Paclitaxel, Carboplatin And Low Dose Radiation As Induction Therapy In Locally Advanced Head And Neck CancerCompletedNCT00176267Phase 2
• Phase I Trial of Biweekly Gemcitabine & Paclitaxel & Low-Dose Radiation for Metastatic or Recurrent Head & Neck CancerTerminatedNCT00176241Phase 1
• Beta-carotene and Alpha-tocopherol Chemoprevention of Second Primary Malignancies in Head and Neck Cancer PatientsCompletedNCT00169845Phase 3
• Post-operative Radiotherapy With Cisplatin Alone or in Combination With Iressa in Upper Aerodigestive Tract CarcinomasTerminatedNCT00169221Phase 2
• Trial Comparing Oral Pilocarpine (Salagen) Versus Submandibular Salivary Gland Transfer Protocol, For the Prevention of Radiation (XRT) Induced Xerostomia in Head and Neck Cancer PatientsCompletedNCT00168181Phase 3
• Xerostomia in Head and Neck Cancer Patients Receiving Radiation as the Primary Treatment Versus Patients Who Will Not Have Such a ProcedureCompletedNCT00168116Phase 2
• Study of Amifostine and IMRT for Protecting Salivary Glands in Head and Neck CancerCompletedNCT00167908Phase 2
• Value of FLT-PET Before and During Radiotherapy in Head and Neck TumorsCompletedNCT00163176
• Validation of 18F-MISO-PET and 18F-FLT-PETTerminatedNCT00159978
• Intravenous Versus Subcutaneous Amifostine in Prevention of Xerostomia After RT for Head and Neck CarcinomasCompletedNCT00158691Phase 3
• Subcutaneous Amifostine Safety StudyCompletedNCT00158041Phase 4
• Does Tranexamic Acid Administration Reduce Blood Loss During Head and Neck Surgery?CompletedNCT00147862Phase 3
• Positronic Emission Tomography (PET) Imaging in Post Radiation Evaluation of Head and Neck Tumours (PET PREVENT Trial)CompletedNCT00147472Phase 3
• Study of Biological Effect of Tarceva (OSI-774) for Patients Stricken by ENT Epidermoid CarcinomaCompletedNCT00144976Not applicable
• Mouth Care Regimes During RadiotherapyCompletedNCT00138827Phase 4
• Using Intensity-Modulated Radiation Therapy to Permit Sparing of Parotid Gland FunctionCompletedNCT00137475Phase 1/2
• Feasibility Study of Incorporating 18F-FDG-PET Imaging in Radiotherapy for Head and Neck CancerCompletedNCT00135161Phase 1
• A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Advanced Head and Neck CancerCompletedNCT00131638Phase 3
• Toxicities Associated With Subcutaneous Administration of Ethyol (Amifostine) for the Prevention of Radiation-Induced ToxicitiesCompletedNCT00130143Not applicable
• Clinical Trial of New Elastomer for Maxillofacial ProstheticsCompletedNCT00123097Phase 3
• A Study of Gene Polymorphisms and Normal Tissue Radiation Injury in Patients Treated for Breast, Prostate, Brain, Lung, and Head and Neck CancersStatus unknownNCT00122239
• Trial of Five Versus Six Fractions Per Week for Head and Neck CancerCompletedNCT00120211Phase 3
• A Study of OSI-7904L as Treatment in Patients With Head and Neck Cancer Who Have Failed First-Line TherapyCompletedNCT00116909Phase 2
• Boronophenylalanine (BPA)-Based Boron Neutron Capture Therapy (BNCT) in the Treatment Head and Neck TumorsCompletedNCT00114790Phase 1/2
• Carboplatin, Capecitabine, and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck CancerCompletedNCT00114153Phase 1
• Erlotinib and Docetaxel With Concomitant Boost Radiation Therapy (XRT) for Head and Neck Squamous Cell Carcinoma (HNSCC)CompletedNCT00113347Phase 1
• A Smoking, Alcohol, and Depression Intervention for Head and Neck CancerCompletedNCT00105651Not applicable
• 4-HPR and FTI in Head and Neck Squamous Cell Carcinoma (HNSCC)TerminatedNCT00102635Phase 1
• Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung CancerCompletedNCT00101348Phase 1/2
• Celecoxib in Preventing Head and Neck Cancer in Patients With Oral LeukoplakiaCompletedNCT00101335Phase 2
• Salivary Proteins in Disease and HealthCompletedNCT00100204
• NGR-TNF in Treating Patients With Advanced Solid TumorsCompletedNCT00098943Phase 1
• Lapatinib in Treating Patients With Recurrent and/or Metastatic Head and Neck CancerCompletedNCT00098631Phase 2
• S0420, Sorafenib in Treating Patients With Recurrent or Metastatic Head and Neck CancerCompletedNCT00096512Phase 2
• Randomized Amifostine For SCCHNCompletedNCT00095927Phase 2
• Capecitabine For Nasopharyngeal CancerCompletedNCT00095901Phase 2
• Concomitant Radiation and Cisplatin With and Without Tirapazamine in Treatment of Advanced Head and Neck CancerCompletedNCT00094081Phase 3
• Acupuncture or Standard Therapy in Treating Pain and Dysfunction in Patients Who Have Undergone Neck Surgery for Head and Neck CancerCompletedNCT00090337Phase 3
• Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid TumorsCompletedNCT00089362Phase 1
• S0217, Adjuvant Cisplatin and Docetaxel After Complete Resection Stage III or IV Head and Neck CancerWithdrawnNCT00084435Phase 2
• Parotid-Sparing Intensity-Modulated Radiation Therapy Compared With Conventional Radiation Therapy in Treating Patients With Oropharyngeal or Hypopharyngeal Cancer Who Are at High Risk of Radiation-Induced XerostomiaStatus unknownNCT00081029Phase 3
• Motexafin Gadolinium With Chemotherapy and Radiation Therapy for the Treatment of Advanced Head and Neck CancerTerminatedNCT00080028Phase 1
• Study of Lonafarnib in Patients With Recurrent Squamous Cell Carcinoma of the Head and Neck (Study P02530)TerminatedNCT00073450Phase 2
• Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung CancerCompletedNCT00068497Not applicable
• Immunotoxin Therapy in Treating Patients With Advanced Solid TumorsCompletedNCT00066651Phase 1
• Perifosine in Treating Patients With Recurrent or Metastatic Head and Neck CancerTerminatedNCT00062387Phase 2
• Boronophenylalanine-Fructose Complex (BPA-F) and/or Sodium Borocaptate (BSH) Followed By Surgery in Treating Patients With Thyroid Cancer, Head and Neck Cancer, or Liver MetastasesCompletedNCT00062348Phase 1
• Celecoxib in Treating Patients With Progressive Metastatic Differentiated Thyroid CancerCompletedNCT00061906Phase 2
• Celecoxib in Treating Patients With Early-Stage Head and Neck Cancer or Non-Small Cell Lung CancerCompletedNCT00058006Phase 2
• BMS-247550 Plus Cisplatin in Treating Patients With Metastatic or Recurrent Head and Neck CancerCompletedNCT00057850Phase 1/2
• Study of Intralesional Injection of M4N in Patients With Refractory Malignant Tumors of the Head and NeckCompletedNCT00057512Phase 1
• Safety of GM-CT-01 With and Without 5-Fluorouracil in Patients With Solid TumorsCompletedNCT00054977Phase 1
• Isotretinoin, Interferon Alfa, and Vitamin E in Treating Patients With Stage III or Stage IV Head and Neck CancerCompletedNCT00054561Phase 3
• S0216, Combination Chemotherapy and RT in Treating Patients With Stage III or Stage IV Head and Neck CancerCompletedNCT00054054Phase 2
• Celecoxib in Preventing Cancer in Patients With Oral Leukoplakia and/or Head and Neck DysplasiaCompletedNCT00052611Phase 2
• Phase II Trial of Allovectin-7® for Head and Neck CancerCompletedNCT00050388Phase 3
• Erlotinib, Docetaxel, and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck CancerCompletedNCT00049283Phase 1
• EF5 Compared With Other Methods of Detecting Oxygen Levels in Tumor Cells of Patients With Head and Neck CancerCompletedNCT00049140Phase 2
• Diagnostic Trial in Patients Who Are Undergoing Surgery for Early Stage Mouth CancerCompletedNCT00042926Not applicable
• Docetaxel and St. John's Wort in Treating Patients With Solid Tumors That Cannot Be Removed By SurgeryWithdrawnNCT00041171Phase 3
• Irinotecan and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Head and Neck CancerCompletedNCT00040807Phase 2
• A Phase IB Study Of Oral SCH 66336 Preoperatively In Patients With Head And Neck Squamous Cell CancerCompletedNCT00038584Phase 1
• Assessment of Head and Neck Tumor Hypoxia Using 18F-FluoromisonidazoleWithdrawnNCT00038038Not applicable
• Zinc Sulfate in Preventing Loss of Sense of Taste in Patients Undergoing Radiation Therapy for Head and Neck CancerCompletedNCT00036881Phase 3
• Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced CancerCompletedNCT00036790Phase 1
• Ixabepilone in Treating Patients With Metastatic or Recurrent Squamous Cell Cancer of the Head and NeckCompletedNCT00033618Phase 2
• 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)CompletedNCT00031681Phase 1
• Erlotinib and Cisplatin in Treating Patients With Recurrent or Metastatic Head and Neck CancerCompletedNCT00030576Phase 1/2
• Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney DysfunctionCompletedNCT00030498Phase 1
• Photodynamic Therapy System for Patients With Refractory/Unresponsive Solid TumorsCompletedNCT00028405Phase 1

← Head and Neck Neoplasms overview